ScandiDos AB (SE:SDOS)

:SDOS

SDOS

ScandiDos AB

RESEARCH TOOLSreports

Want to see SE:SDOS full AI Analyst Report?

ScandiDos AB (SDOS) Price & Analysis

0 Followers

SDOS Stock Chart & Stats

kr1.15

kr0.01(0.67%)

At close: Mar 06 4:00 PM EST

kr1.15

kr0.01(0.67%)

Day’s Range― - ―

52-Week Rangekr0.85 - kr1.50

Previous CloseN/A

Volume16.76K

Average Volume (3M)69.69K

Market Cap

kr51.02M

Enterprise Valuekr53.44M

Total Cash (Recent Filing)kr5.85M

Total Debt (Recent Filing)kr0.00

Price to Earnings (P/E)―

Beta0.39

Next Earnings

Jun 16, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.07

Shares Outstanding57,011,086

10 Day Avg. Volume66,689

30 Day Avg. Volume69,692

Financial Highlights & Ratios

PEG Ratio0.00

Price to Book (P/B)1.28

Price to Sales (P/S)0.95

P/FCF Ratio-21.18

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Debt-free Balance SheetA near-zero debt position gives ScandiDos durable financial flexibility: it can fund short-term operating needs, prioritize R&D or service expansion, and withstand continued cash burn without immediate solvency pressure. This structural strength lowers refinancing risk and preserves strategic optionality.

Narrowing LossesMaterial reduction in losses versus prior years signals improving cost control and operational leverage. Sustained narrowing creates a credible path toward break-even and eventual profitability, making future cash generation more attainable if top-line stabilizes and efficiency gains continue.

Niche Radiotherapy QA MarketScandiDos operates in a specialized, mission-critical niche—radiotherapy QA—where clinical accuracy and patient safety drive durable demand. This focused product set can create high switching costs, long customer relationships, and opportunities for software/licenses and service contracts that enhance long-term revenue visibility.

Bears Say

Revenue ContractionA trailing-12-month revenue decline weakens scale economics, making it harder to cover fixed R&D and support costs. Persistent top-line shrinkage can stall margin recovery and delay sustainable profitability, reducing the firm's ability to reinvest in products or expand commercial reach without external funding.

Negative Cash GenerationConsistent negative operating and free cash flow implies ongoing cash burn and reliance on financing or equity to fund operations. Even with reduced losses, failure to convert earnings into positive cash flow limits reinvestment capacity and raises execution risk for product rollouts and service scale-up.

Unclear Recurring Revenue MixDependence on transactional hardware sales rather than a clearly established recurring-license or service model creates revenue volatility and weaker predictability. Limited visible recurring streams constrain margin sustainability and make long-term cash flow planning and valuation of installed base services harder.

SDOS FAQ

What was ScandiDos AB’s price range in the past 12 months?

ScandiDos AB lowest stock price was kr0.85 and its highest was kr1.50 in the past 12 months.

What is ScandiDos AB’s market cap?

ScandiDos AB’s market cap is kr51.02M.

When is ScandiDos AB’s upcoming earnings report date?

ScandiDos AB’s upcoming earnings report date is Jun 16, 2026 which is in 7 days.

How were ScandiDos AB’s earnings last quarter?

ScandiDos AB released its earnings results on Mar 18, 2026. The company reported -kr0.03 earnings per share for the quarter, missing the consensus estimate of N/A by -kr0.03.

Is ScandiDos AB overvalued?

According to Wall Street analysts ScandiDos AB’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does ScandiDos AB pay dividends?

ScandiDos AB does not currently pay dividends.

What is ScandiDos AB’s EPS estimate?

ScandiDos AB’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does ScandiDos AB have?

ScandiDos AB has 57,011,086 shares outstanding.

What happened to ScandiDos AB’s price movement after its last earnings report?

ScandiDos AB reported an EPS of -kr0.03 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -6.99%.

Which hedge fund is a major shareholder of ScandiDos AB?

Currently, no hedge funds are holding shares in SE:SDOS

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

ScandiDos AB

ScandiDos AB (publ), established in Uppsala, Sweden, in 2005, develops advanced measurement systems and software specifically for the quality assurance (QA) and validation demands of innovative medical treatments utilized in clinics worldwide. Their flagship Delta4 Family solution offers comprehensive dose verification, both before and during treatment, across a wide array of radiation therapy techniques, including VMAT, IMRT, SBRT, 4D-RT, and TomoTherapy. The Delta4 Discover is a transmission detector providing real-time measurements to bolster confidence and patient safety. Additionally, the Delta4 Phantom+ system ensures accurate verification of IMRT, VMAT, and TomoTherapy plans. The company's product line also includes HexaMotion, a dedicated solution for motion management. Their software offerings comprise Delta4DVH Anatomy, which verifies and analyzes the administered dose within a patient's anatomical structures, and Delta4 Machine QA, designed for conducting quality checks on machine rotation, start-up performance, and dynamic beam modulation.